SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-16-767879
Filing Date
2016-11-14
Accepted
2016-11-14 17:01:04
Documents
1
Group Members
CHARLES SERMONDENISE SCOTS-KNIGHT, PH.D.DR. ALASTAIR MCKINNONPHASE4 VENTURES III GENERAL PARTNER LTDPHASE4 VENTURES III GP LPPHASE4 VENTURES III LP

Document Format Files

Seq Description Document Type Size
1 SC 13D d286204dsc13d.htm SC 13D 160038
  Complete submission text file 0001193125-16-767879.txt   161885
Mailing Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109
Business Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Subject) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83386 | Film No.: 161995775
SIC: 2834 Pharmaceutical Preparations

Mailing Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ
Business Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ 44 0 20 3036 0050
Phase4 Partners Ltd (Filed by) CIK: 0001600023 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D